Thomas Broekhoff is a dedicated and experienced Project Manager at hollandbio, a leading organization in the biotechnology and pharmaceutical industry. With a strong background in science and advocacy, Thomas is committed to driving innovation and collaboration within the orphan drug industry.
Thomas' expertise lies in strategic planning, partnership building, and stakeholder engagement, making him a valuable asset in the complex landscape of orphan drug development.
Throughout his career, Thomas has demonstrated a passion for improving the lives of patients with rare diseases by championing the development of innovative orphan drugs. He is known for his ability to navigate regulatory challenges, foster cross-sector partnerships, and advocate for policies that support orphan drug research and access.
As a speaker at the World Orphan Drug Congress 2025, Thomas will share his insights on effective strategies, advocacy efforts, and partnership models that are crucial for the success of the orphan drug industry. His practical knowledge and forward-thinking approach make him a sought-after expert in the field, driving positive change and advancements in orphan drug development.
-Case study example of multi-year, multi-indication (MYMI) agreements in Belgium, Italy, Netherlands and UK